Search Results 411-420 of 16234 for Chronic Lymphocytic Leukemia
Subjects must have a histologically confirmed diagnosis of relapsed or refractory disease. For Chronic lymphocytic leukemia (CLL) Subjects: Subjects must ...
Chronic lymphocytic leukemia, Non-Hodgkin's lymphoma, Hodgkin lymphoma. Rahma Warsame, M.D.. Internist; Hematologist. Rochester, MN ...
Study of Lenzilumab (KB003) in Previously Treated Patients With Chronic Myelomonocytic Leukemia (CMML) · Overview · Participation eligibility · Participating Mayo ...
Granuloma annulare-like eruption associated with B-cell chronic lymphocytic leukemia. J Cutan Pathol. 2012 Nov; 39(11):996-1003. Epub 2012 Jul 25. View ...
... chronic lymphocytic leukemia (CLL)/non-Hodgkin lymphoma (NHL). The study will also aim to evaluate the use of immunostains during MMS to improve the ...
A Study to Evaluate Minimal Residual Disease in Chronic Lymphocytic Leukemia. Rochester, Minn. The purpose of this study is to compare whether minimal ...
Increased incidence of malignant melanoma and other rare cutaneous cancers in the setting of chronic lymphocytic leukemia. Int J Dermatol. 2015 Aug; 54: (8)e287 ...
Chronic lymphocytic leukemia · Churg-Strauss syndrome · Colon cancer · Colon polyps · Constipation in children · Crohn's disease · Cyclic vomiting syndrome.
Targeted drug therapies have greatly improved outcomes for patients with relapsed or refractory (R/R) chronic lymphocytic leukemia (CLL) and non-Hodgkin's ...
... chronic lymphocytic leukemia (CLL) and B-cell acute lymphoblastic leukemia (B-cell ALL) using primary tumor and/or patient derived xenograft models, and to ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine.